Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
02/1996
02/29/1996WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists
02/29/1996WO1996006079A1 Biphenylamide derivatives as 5ht1d antagonists
02/29/1996WO1996006078A1 N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists
02/29/1996WO1996006077A1 N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor antagonists
02/29/1996WO1996006074A1 Metalloproteinase inhibitors
02/29/1996WO1996005857A1 Device for delivery of substances and methods of use thereof
02/29/1996WO1996005856A1 Human chemokine polypeptides
02/29/1996WO1996005855A1 Cartilage disease remedy
02/29/1996WO1996005851A1 Use of tasteless, hydrolysed collagen and agent containing the same
02/29/1996WO1996005842A1 Intravenous alendronate formulations
02/29/1996WO1996005829A1 Methods of maintaining teeth and oral bone
02/29/1996WO1996005828A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
02/29/1996WO1996005826A1 Methods of reducing scarring in wound healing
02/29/1996WO1996005825A1 Methods for bone healing and fracture repair
02/29/1996WO1996005824A1 Methods for inhibiting bone prosthesis degeneration
02/29/1996WO1996005820A1 Hyperlipemia remedy
02/29/1996WO1996005816A1 Treatment of animals
02/29/1996DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other
02/29/1996CA2517691A1 Endothelin antagonists
02/29/1996CA2198452A1 Treatment of animals
02/29/1996CA2198368A1 Hyperlipemia remedy
02/29/1996CA2198242A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
02/29/1996CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells
02/29/1996CA2198206A1 Human chemokine beta-9
02/29/1996CA2198118A1 Methods for inhibiting bone prosthesis degeneration
02/29/1996CA2198108A1 Methods of maintaining teeth and oral bone
02/29/1996CA2198012A1 Methods for bone healing and fracture repair
02/29/1996CA2198011A1 Methods of reducing scarring in wound healing
02/29/1996CA2197864A1 Peptide libraries as a source of syngenes
02/29/1996CA2196979A1 7-azabicyclo¬2.2.1|-heptane and -heptene derivatives as cholinergic receptor ligands
02/29/1996CA2188948A1 Device for delivery of substances and methods of use thereof
02/28/1996EP0698594A1 Pharmaceutical anthraquinone derivatives
02/28/1996EP0698392A1 Compositions containing a RAR alpha specific ligand and at least one fatty acid
02/28/1996EP0698095A1 Bmp-10 compositions
02/28/1996EP0698094A1 Bmp-11 compositions
02/28/1996EP0698087A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer
02/28/1996EP0698040A1 Lhrh antagonists
02/28/1996EP0698025A1 Ampa antagonists and a method of treatment therewith
02/28/1996EP0698012A1 Novel deoxygalactonojirimycin derivatives
02/28/1996EP0698010A1 N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
02/28/1996EP0697890A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
02/28/1996EP0697886A1 New peptide antagonists at glutamate and nmda receptors
02/28/1996EP0697882A1 Use of glutathione diesters
02/28/1996EP0697880A1 Inhibition of leukocyte adhesion
02/28/1996EP0697876A1 Xenograft thymus
02/28/1996EP0697874A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
02/28/1996EP0697873A1 Olefin-substituted long chain compounds
02/28/1996EP0697871A1 Treatment process with biologically active tropane derivatives
02/28/1996EP0697870A1 Btp receptor modulator of the gaba a?/chloride channel complex for prolonging the duration of the gaba induced membrane current
02/28/1996EP0697869A1 Transdermal therapeutic systems for the administration of serotonin agonists
02/28/1996EP0697863A1 Use of dihydroliponic acid as an ophthalmologic agent and for the suppression of incompatability reactions at the interfaces between implants and living body tissue
02/28/1996EP0697859A1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions
02/28/1996EP0693051A4 Cyclopentene derivatives as endothelin receptor antagonists
02/28/1996EP0630644A4 Anti-microbial and interferon-inducing pharmaceutical compound.
02/28/1996EP0588897B1 Non-chlorofluorocarbon aerosol formulations
02/28/1996EP0494978B1 Heterocyclic compounds
02/28/1996EP0362367B1 Osteogenic devices
02/27/1996US5495043 Substituted di-t-butylphenols
02/27/1996US5495021 Benzo[f]quinolinones
02/27/1996US5494928 Indole derivatives
02/27/1996US5494925 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
02/27/1996US5494918 Anticholesterol agents
02/27/1996US5494916 Imidazo[4,5-C]pyridin-4-amines
02/27/1996US5494910 Benzofuran derivatives as 5-HT1 -like receptor antagonists
02/27/1996US5494907 11-β substituted-19-nor steroids
02/27/1996US5494906 Treating metabolic bone disease
02/27/1996US5494670 Method of treating ketosis
02/27/1996CA2155447A1 Substituted biphenyl isoxazole sulfonamides
02/27/1996CA1338089C Sulfonic acid esters
02/26/1996CA2156788A1 Use of 6-amino-1,4-dihydropyridines as medicaments for treatment of the central nervous system, and processes for their preparation
02/26/1996CA2156673A1 Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments
02/25/1996CA2156700A1 Pharmaceutical compounds
02/22/1996WO1996005321A1 Gene therapy for restenosis using an adenoviral vector
02/22/1996WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase
02/22/1996WO1996005301A1 Novel vesicular acetylcholine carrier
02/22/1996WO1996005289A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor
02/22/1996WO1996005288A2 T cell activation
02/22/1996WO1996005225A1 Adrenergic receptor
02/22/1996WO1996005221A1 Calcitonin receptor
02/22/1996WO1996005203A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents
02/22/1996WO1996005200A1 TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO[2,3-b]PYRIDINE
02/22/1996WO1996005193A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists
02/22/1996WO1996005190A1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists
02/22/1996WO1996005187A1 (4-(3-aminomethylphenyl)thiazol-2-yl)-guanidines as h2-receptor antagonists
02/22/1996WO1996005185A1 Novel alkylamino derivatives as sigma 2 selective ligands
02/22/1996WO1996005181A1 Morpholine derivatives and their use as therapeutic agents
02/22/1996WO1996005177A1 Novel pyrimidine derivatives and processes for the preparation thereof
02/22/1996WO1996005165A1 Retinoic acid x-receptor ligands
02/22/1996WO1996005160A1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
02/22/1996WO1996004928A1 Calcitonin gene related peptide receptor
02/22/1996WO1996004926A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ η1 CHAIN
02/22/1996WO1996004923A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides
02/22/1996WO1996004917A1 Remedy for myotonic dystrophy
02/22/1996WO1996004916A1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
02/22/1996WO1996004901A1 Composition and method for treating anxiety
02/22/1996WO1996004900A1 Composition and method for protection against drug dependency
02/22/1996WO1996004894A1 Anti-acne cosmetic compositions
02/22/1996WO1996001110A3 Anti-hiv triple combination
02/22/1996WO1996000068A3 Combination therapy for hiv infection
02/22/1996CA2197801A1 T cell activation
1 ... 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 ... 1564